Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Miguel, Rita | Correia, Ana Sofia Aleixo; | Bugalho, Paulo;
Affiliations: Neurology Department, Hospital Egas Moniz (Centro Hospitalar Lisboa Ocidental), Lisboa, Portugal | CEDOC, Chronic Diseases Research Center, Faculty of Medical Sciences, Universidade Nova de Lisboa, Lisboa, Portugal
Note: [] Correspondence to: Rita Miguel, MD, Neurologia, Hospital Egas Moniz (Centro Hospitalar Lisboa Ocidental), Rua da Junqueira, 126, 1349-019 Lisboa, Portugal. Tel.: +351 210432179; E-mail: [email protected]
Abstract: We performed a clinical report based, descriptive and retrospective study, aimed at comparing Flunarizine/Cinnarizine-induced parkinsonism (FCIP) patients and Parkinson's disease (PD) patients. The FCIP group (n = 30) presented a lower frequency of rigidity and unilateral tremor than the PD group (n = 70). All FCIP patients improved, 13 after dopaminergic treatment. FCIP patients who improved spontaneously presented lower frequency of rigidity, compared with the other FCIP subgroup and PD group. FCIP patients who did not improve spontaneously showed a clinical pattern similar to PD patients.
Keywords: Calcium channel blockers, cinnarizine, drug-induced parkinsonism, flunarizine, nigrostriatal pathway, Parkinson's disease
DOI: 10.3233/JPD-140414
Journal: Journal of Parkinson's Disease, vol. 4, no. 4, pp. 645-649, 2014
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]